Saxagliptin, in combination with metformin, provides a durable, well-tolerated, and cost-effective treatment option for patients with type 2 diabetes mellitus, from a US payer perspective.
Michelle Sriprasert, MPH
Advertisement
Articles by Michelle Sriprasert, MPH
Advertisement
Latest Updated Articles
- US Cost-Effectiveness of Saxagliptin in Type 2 Diabetes Mellitus
February 10th 2012
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Should Know About Novo Nordisk-Eli Lilly GLP-1 Ad Suit
2
Overlooked Coronavirus Protein May Drive Cytokine Storm, Cardiac Injury in Severe COVID-19
3
FDA Clears First Continuous Glucose-Ketone Monitor
4
FDA Grants Fast Track Designation to ERAS-0015 for Metastatic Pancreatic Cancer
5